Hosonaga, M.; Arima, Y.; Sampetrean, O.; Komura, D.; Koya, I.; Sasaki, T.; Sato, E.; Okano, H.; Kudoh, J.; Ishikawa, S.;
et al. HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer. Int. J. Mol. Sci. 2018, 19, 2158.
https://doi.org/10.3390/ijms19082158
AMA Style
Hosonaga M, Arima Y, Sampetrean O, Komura D, Koya I, Sasaki T, Sato E, Okano H, Kudoh J, Ishikawa S,
et al. HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 2018; 19(8):2158.
https://doi.org/10.3390/ijms19082158
Chicago/Turabian Style
Hosonaga, Mari, Yoshimi Arima, Oltea Sampetrean, Daisuke Komura, Ikuko Koya, Takashi Sasaki, Eiichi Sato, Hideyuki Okano, Jun Kudoh, Shumpei Ishikawa,
and et al. 2018. "HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer" International Journal of Molecular Sciences 19, no. 8: 2158.
https://doi.org/10.3390/ijms19082158
APA Style
Hosonaga, M., Arima, Y., Sampetrean, O., Komura, D., Koya, I., Sasaki, T., Sato, E., Okano, H., Kudoh, J., Ishikawa, S., Saya, H., & Ishikawa, T.
(2018). HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer. International Journal of Molecular Sciences, 19(8), 2158.
https://doi.org/10.3390/ijms19082158